FDA issued a Warning Letter to US Specialty Formulations LLC on 9/30/2016 for a previous inspection.
483 US Specialty Formulations Aug 2017

483 US Specialty Formulations Aug 2017

James Mason FDA, John Mastalski FDA$119.00 - Available Now

FDA investigators audited the US Specialty Formulations - Bethlehem, PA, United States facility and issued inspectional observations (via FDA 483) on 29 Aug 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Aug 2017
  • Location: Bethlehem, United States
  • FEI: 3010680515
Add To Cart